Maxpro Capital Acquisition Corp.

Status: Deal Closed
U=S+W W=S@11.50
IPO Proceeds, $M $103.50M
IPO Date Oct 8, 2021
CEO Chen, Hong - Jung (Moses)
Left Lead EF Hutton
IPO Cash in Trust 101.5%
SPAC Tenor 12 + 3 + 3
IPO Sector Healthcare

Healthcare and technology

IPO Geography Global
Target Company Apollomics
Deal Announced Sep 14, 2022
Deal Size, $M $800.00M
Deal Sector Healthcare
Deal Geography Global
SEC Filings www.sec.gov
Approval Vote Mar 20, 2023
Amendment Vote TBD
Closing Date Mar 30, 2023
Formerly JMAC APLM APLMW

Sign up for Free Trial

No credit card required

Sign in for more on Maxpro Capital Acquisition Corp.:

  • Structure and cap table
  • 6 directors & officers
  • 18 filings and events
  • 6 underwriters
  • 2 deal advisors
  • 2 legal advisors
Structure

Sign in to view structure, cap table, and calendar of events.

Team
Name Age Title
Chen, Hong - Jung (Moses) 61 Chairman, Chief Executive Officer and Director
Gau, Wey – Chuan (Albert) 60 Chief Financial Officer and Director
Song, Yung-Fong (Ron) 60 Chief Strategy Officer
Chen, Yi - Kuei (Alex) 52 Director
Wu, Soushan 71 Director
Noha Georges 47 Director

Sign in to view team biographies and more sponsor and affiliate data.

Advisors
Underwriters
EF Hutton BR 1,525,500 units
Joseph Gunnar 1,220,300
US Tiger Securities 3,000,000
AmeriVet Securities 1,220,300
Ingalls & Snyder 1,016,950
Drexel Hamilton 1,016,950
9,000,000 units
Up-Front UW fee 2.00 %
Deferred UW fee 3.50 %

Sign in to view more advisor data.

Deal

Sign in to view merger details and deal financials.

Filings

Sign in to view 18 filings.

Shareholders

Sign in to view shareholders 13F filing data.